All News

Lungs ILD

Best of 2022: Approach to ILD in Myositis Syndromes

d Jack Cush, MD

Mehta et al have published a full read review of managing interstitial lung disease (ILD) in patients with inflammatory myopathies, a heterogeneous group of syndromes connected by ILD and and increased morbidity and mortality risk.

Read Article
RheumNow Podcast square

Fever, FROST, & Pericarditis (12.16.2022)

d Jack Cush, MD

Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK".

Read Article
covid vaccine needle vaccination

COVID-19 Vaccine Responses in Rheumatic Disease Patients

d Jack Cush, MD

Nature Reviews Rheumatology features a review of three notable papers that address the impact of SARS-CoV-2 vaccination on people with inflammatory rheumatic disease. 

Read Article
ild.jpg

JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD

d Jack Cush, MD

The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected. This review examines the available clinical literature on the potential benefits and outcomes of JAK inhibitor use in SSc=ILD.

Read Article
The First Head to Head trial in Axial SpA Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic AxSpA: A Randomized Phase IIIb Study https://t.co/J0DT1yw0vQ https://t.co/kKhFQKAy6H

Links:

Dr. John Cush RheumNow ( View Tweet)
Practical Guidance for the Clinical Rheumatologist in Unplanned Pregnancies Women of reproductive age comprise an overwhelming majority of patients with rheumatic and musculoskeletal disease. https://t.co/x44GTLRtnT https://t.co/YlLgqeDRgP

Links:

Dr. John Cush RheumNow ( View Tweet)
2022 ACR/EULAR Giant Cell Arteritis Classification Criteria Giant cell arteritis (GCA) has historically been a clinical diagnosis (visual loss, headache, jaw pain, scalp tenderness, etc) supported by labs and histopathology. https://t.co/DN82rXco3N https://t.co/dpIixCFseT

Links:

Dr. John Cush RheumNow ( View Tweet)
73-87% of autoimmune (RA, SLE, UCTD, APL) pts used HCQ during pregnancy. HCQ significantly reduced pre-eclampsia (20% vs 9%), early-onset pre-eclampsia (8% vs 2.5%), 2nd/3rd trimester pregnancy loss (3% vs. 0.6%) https://t.co/CF5ivHeCmY https://t.co/CYqaCCuZJz

Links:

Dr. John Cush RheumNow ( View Tweet)
Fever, FROST, & Pericarditis Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK. https://t.co/IFxocGkOxJ https://t.co/OzoS248ZRK

Links:

Dr. John Cush RheumNow ( View Tweet)

Review of the Rheumatic causes of Pericarditis and their management. Causes: SLE, RA, MCTD, Myositis, EGPA, GPA, IgG4-rel Dz, FMF, TRAPS, CAPS, AOSD, JIA, Sarcoidosis, Kawasakis, GCA, Takayasu's https://t.co/MQmkUe4Yey https://t.co/FSfrznoeBe

Links:

Dr. John Cush RheumNow ( View Tweet)
JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected. https://t.co/LWHKO0gRu4 https://t.co/i2IOLcAgt3

Links:

Dr. John Cush RheumNow ( View Tweet)
New download available-GCA and PMR New Drugs https://t.co/7Y4g6zvTQx. https://t.co/ZfVO0SRVuL

Links:

Dr. John Cush RheumNow ( View Tweet)
CXCL5 Therapy in Lupus? A new study has shown that restoring the balance of a protein in blood may be a promising treatment option for systemic lupus erythematosus, or lupus, an incurable autoimmune disease. https://t.co/B82Xq5FFNJ. https://t.co/ba2nlFuDsI

Links:

Dr. John Cush RheumNow ( View Tweet)
Low dose steroids can negatively impact bone health Dr. Janet Pope discusses abstract L01 presented at ACR22. https://t.co/eBGMza9tWE https://t.co/wACnLTxATu

Links:

Dr. John Cush RheumNow ( View Tweet)
The First Head to Head trial in Axial SpA Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic AxSpA: A Randomized Phase IIIb Study https://t.co/RgwKRJwgoS https://t.co/6LxOURICiE

Links:

Dr. John Cush RheumNow ( View Tweet)
Marginal Benefit with Diet and Exercise in Obese Knee Osteoarthritis Patients The easiest intervention for knee osteoarthritis (diet and exercise) is also the most difficult for many patients; but do these work? https://t.co/s4Gzmh2gGZ https://t.co/aZORTMtCvs

Links:

Dr. John Cush RheumNow ( View Tweet)
Get the Skinny on Bimekizumab in PsA Dr. Janet Pope discusses abstract presented at #ACR22. https://t.co/FKFARxQ2fa https://t.co/wSyXeSHII3

Links:

Dr. John Cush RheumNow ( View Tweet)
During 2021–22 FLU season, 6% of hosp pedi-influenza pts had SARS-CoV-2 coinfection; these required more respiratory support. Risk of influenza death augmented by not recv vaccination (flu or covid), no antiviral Rx, comorbidities & coinfx w/COVID https://t.co/bfjeClHflW https://t.co/YTOEnNSQQN

Links:

Dr. John Cush RheumNow ( View Tweet)
Lupus Research Alliance announced 2022 Distinguished Innovator Award recipients: - Hongbo Chi, PhD, Exploring Metabolism of Follicular Helper T Cells & Lupus Progression - Joseph Craft, MD: Processes Enabling T Cells to Be Destructive in Lupus Nephritis https://t.co/yI2NlCHaBi https://t.co/fevBTkaxCY

Links:

Dr. John Cush RheumNow ( View Tweet)
#OA phenotypes by SF cell status - Activated: hi T-cell, low mono–macrop-PMN activated; 70% improved - Lymphoid: hi PMN, low lymph & mono, low activ, lower pain - Myeloid: hi NK & mono, low T-cell & activat - Aggressive: hi lymph/macr/NK/PMN;39%improve -https://t.co/3DXPoDE5Pm https://t.co/VRJkscAm5a

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×